- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 45 Years - 99 Years
- Sexes
- All
Treats Adults
Dominick J Angiolillo, MD, PhD
Cardiologist, Interventional Cardiologist
Dominick J Angiolillo, MD, PhD
- Additional languages:
- Italian,
- Spanish
(904) 383-1011
Request appointment online
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 416 publications
- Percutaneous Coronary Intervention , 211 publications
- Clopidogrel , 189 publications
- Ticlopidine , 158 publications
Research activity
Active clinical trials
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All
- Investigator
- Dominick J Angiolillo
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All
My publications
Filter publications
844 publications
2025
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary Syndrome
Journal of the American Heart Association
2025
Cangrelor in percutaneous coronary interventions: advances in evidence, clinical applications, and future directions.
Expert review of cardiovascular therapy
鈥�2025
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis.
Lancet (London, England)
鈥�2025
Reply: sex-related variations in platelet reactivity.
European heart journal. Cardiovascular pharmacotherapy
鈥�2025
Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy.
European heart journal. Cardiovascular pharmacotherapy
鈥�